Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening

Kidney International

Volumn 51, Issue 3, 1997, Pages 850-854

  Iseki, Kunitoshi ^a   Ikemiya, Yoshiharu ^a   Fukiyama, Koshiro ^a  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CREATININE BLOOD LEVEL; FEMALE; HUMAN; JAPAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030934177     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.119     Document Type: Article

References (35)

1. HULL AR, PARKER TF, III: Proceedings from the morbidity, mortality and prescription of dialysis symposium, Dallas, TX, September 15 to 17, 1989. Am J Kidney Dis 15:375-385, 1990
2. ISEKI K, KAWAZOE N, OSAWA A, FUKIYAMA K: Survival analysis of dialysis patients in Okinawa, Japan (1971-1990). Kidney Int 43:404-409, 1993
3. D'AMICO G: Clinical features and natural history in adults with Ig A nephropathy. Am J Kidney Dis 12:353-357, 1988
4. KROLEWSKI AS, WARRAM JH, CHRISTLIEB AR, BUSICK EJ, KAHN CR: The changing natural history of nephropathy in type I diabetes. Am J Med 78:785-794, 1985
5. ANDERSON AR, CHRISTIANSEN JS, ANDERSON JK, KREINER S, DECKERT T: Diabetic nephropathy in Type I insulin-dependent diabetes: An epidemiological study. Diabetologia 25:496-501, 1983
6. HUMPHREY LL, BALLARD DJ, FROHNERT PP, CHU CP, O'FALLON WM, PALUMBO PJ: Chronic renal failure in non-insulin-dependent diabetes mellitus. A population-based study in Rochester, Minnesota. Ann Intern Med 111:788-796, 1989
7. HARRIS MI, KLEIN R, WELBORN TA, KNUIMAN MW: Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care 15:815-819, 1992
8. SUNAGAWA H, ISEKI K, NISHIME K, UEHARA H, TOMA S, KINJO K, FUKIYAMA K: Epidemiologic analysis of diabetic patients on chronic dialysis. Nephron 74:361-366, 1996
9. ISEKI K, ISEKI C, IKEMIYA Y, FUKIYAMA K: Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 49:800-805, 1996
10. MITCH WE, WALSER M, BUFFINGTON GA, LEMANN J JR: A simple method of estimating progression of chronic renal failure. Lancet 2:1326-1328, 1976
11. MITCH WE, WALSER M, STEINMAN TI, HILL S, ZEGER S, TUNGSANGA K: The effect of a keto acid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 311:623-629, 1984
12. RUTHERFORD WE, BLONDIN J, MILLER JP, GREENWELT AS, VAVRA JD: Chronic progressive renal disease: Rate of change of serum creatinine concentration. Kidney Int 11:62-70, 1977
13. CHURCHILL DN, TAYLOR W, COOK RJ, LAPLANTE MMP, BARRE P, CARTIER P, FAY WP, GOLDSTEIN MB, JINDAL K, MANDIN H, MCKENZIE JK, MUIRHEAD N, PARFREY PS, POSEN GA, SLAUGHTER D, ULAN RA, WERB R: Canadian hemodialysis morbidity study. Am J Kidney Dis 19:214-234, 1992
14. HELLERSTEDT WL, JOHNSON WJ, ASCHER N, KJELLSTRAND CM, KNUTSON R, SHAPIRO FL, STERIOFF S: Survival rates of 2,728 patients with end-stage renal disease. Mayo Clin Proc 59:776-783, 1984
15. ISEKI K, KAWAZOE N, FUKIYAMA K: Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int 44:115-119, 1993
16. ISEKI K, KINJO K, KIMUKA Y, OSAWA A, FUKIYAMA K: Evidence for high risk of cerebral hemorrhage in chronic dialysis patients. Kidney Int 44:1086-1090, 1993
17. SAS/STAT, USER'S GUIDE. Release 6.03 Edition, Cary, SAS Institute Inc., 1988
18. KLAG MJ, WHELTON PK, RANDALL BL, NEATON JD, BRANCATI FL, FORD CE, SHULAMN N, STAMLER J: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13-18, 1996
19. WHELTON PK, KLAG MJ: Hypertension as a risk factor for renal disease: Review of clinical and epidemiological evidence. Hypertension 13:S19-S27, 1989
20. MACMAHON S, PETO R, CUTLER J: Blood pressure, stroke, and coronary heart disease. I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335:765-774, 1990
21. BERGSTRÖM J, ALVERSTRAND A, BUCHT H, GUTIERREZ A: Progression of chronic renal failure in man is retarded with more frequent clinical follow-ups and better blood pressure control. Clin Nephrol 25:1-6, 1986
22. BRAZY PC, FITZWILLIAM JF: Progressive renal disease: Role of race and antihypertensive medications. Kidney Int 37:1113-1119, 1990
23. LEWIS EJ, HUNSICKER LG, BAIN RP, ROHDE RD, THE: COLLABORATIVE STUDY GROUP: The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. N Engl J Med 329:1456-1462, 1993
24. YOSHIDA H, MITARAI T, KAWAMURA T, KITAJIMA T, MIYAZAKI Y, NAGASAWA R, KAWAGUCHI Y, KUBO H, ICHIKAWA I, SAKAI O: Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 96:2162-2169, 1995
25. MASCHIO G, ALBERTI D, JANIN G, LOCATELLI F, MANN JFE, MOTOLESE M, PONTICELLI C, RITZ E, ZUCCHELLI P, THE ANGIOTENSIN-CONVERTING-ENZYME INHIBITION IN PROGRESSIVE RENAL INSUFFICIENCY STUDY GROUP: Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Engl J Med 334:939-945, 1996
26. KINJO K, KIMURA Y, SHINZATO Y, TOMORI M, KOMINE Y, KAWAZOE N, TAKISHITA S, FUKIYAMA K, COSMO GROUP: An epidemiological analysis of cardiovascular diseases in Okinawa, Japan. Hypertens Res 15:111-119, 1992
27. KANNEL WB, STAMPFER MJ, CASTELLI WP, VERTER J: The prognostic significance of proteinuria. The Framingham study. Am Heart J 108:1347-1352, 1984
28. HOPPER J JR, TREW PA, BIAVA CG: Membranous nephropathy: Its relative benignity in women. Nephron 29:18-24, 1981
29. DONADIO JV JR, TORRES VE, VELOSA JA, WAGONER RD, HOLLEY KE, OKAMURA M, ILSTRUP DM, CHU C: Idiopathic membranous nephropathy: The natural history of untreated patients. Kidney Int 33:708-715, 1988
30. ISEKI K, MIYASATO F, OURA T, UEHARA H, NISHIME K, FUKIYAMA K: An epidemiologic analysis of end-stage lupus nephritis. Am J Kidney Dis 23:547-554, 1994
31. GRETZ N, ZEIER M, GEBERTH S, STRAUCTH M, RITZ E: Is gender a determinant for evolution of renal disease? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 14:178-183, 1989
32. BRENNER BM, CHERTON GM: Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury. Am J Kidney Dis 23:171-175, 1994
33. KUSUMOTO Y, TAKEBAYASHI S, TAGUCHI T, HARADA T, NAITO S: Long-term prognosis and prognostic indices of IgA nephropathy in juvenile and adult Japanese. Clin Nephrol 28:118-124, 1987
34. ROSSING P, TARNOW L, NIELSEN FS, BOELSKIFTE S, BRENNER BM, PARVING HH: Short statue and diabetic nephropathy. Br Med J 310:296-297, 1995
35. SILBIGER SR, NEUGARTEN J: In-depth review. The impact of gender on the progression of chronic renal disease. Am J Kidney Dis 25:515-533, 1995